Phase 1 Clinical Trial Results Using Satipharm Capsules Published in International Medical Journal Cannabis Investing News
Naturally Splendid Announces $1,500,000 Private Placement, Expands Pitt Meadows Operations Cannabis Investing News
Isodiol International Announces U.S. Sales Launch of Hops-derived CBD Product, ImmunAG™ Cannabis Investing News
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects Biotech Investing
Q BioMed Inc. Announces Funding to Technology Partner Mannin Research Inc. to Expand Product Pipeline Biotech Investing
ChroMedX appoints Ants Kahu & Associates to Implement Quality Management System Medical Device Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
